col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


60 Results       Page 1

 [1] 
Elsevier: Cancer Cell
  original article Date Title Authors   All Authors
1 [GO] 2022―May―30 Impaired humoral immunity is associated with prolonged COVID-19 despite robust CD8 T-cell responses Olga Lyudovyk, Justin Y. Kim, David Qualls, Madeline A. Hwee, Ya-Hui Lin, Sawsan R. Boutemine, et al. (+14)
2 [GO] 2022―May―16 Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies Robert Stuver, Gunjan L. Shah, Neha S. Korde, Lindsey E. Roeker, Anthony R. Mato, Connie L. Batlevi, et al. (+27)
3 [GO] 2022―May―06 COVID-19 vaccines elicit strong cellular immunity and robust clinical protection in CLL Helen Parry, Rachel Bruton, Thomas Roberts, Graham McIlroy, Sarah Damery, Panagiota Sylla, et al. (+23)
4 [GO] 2022―Apr―26 Risk factors for poor humoral response to primary and booster SARS-CoV-2 vaccination in hematologic and oncological outpatients - COVIDOUT study Martin Schönlein, Victoria Wrage, Susanne Ghandili, Sibylle C. Mellinghoff, Thomas Theo Brehm, Lisa B. Leypoldt, et al. (+15)
5 [GO] 2022―Apr―21 COVID-19 in patients with lymphoproliferative diseases during the Omicron variant surge Yotam Bronstein, Roi Gat, Shai Levi, Yael C. Cohen, Efrat Luttwak, Noam Benyamini, et al. (+9)
6 [GO] 2022―Apr―20 Longitudinal COVID-19 vaccination-induced antibody responses and Omicron neutralization in patients with lung cancer Philip C. Mack, Jorge E. Gomez, Ananda M. Rodilla, Juan Manuel Carreño, Chih-Yuan Hsu, Christian Rolfo, et al. (+24)
7 [GO] 2022―Apr―12 Enhanced SARS-CoV-2 breakthrough infections in patients with hematologic and solid cancers due to Omicron Maximilian J. Mair, Manfred Mitterer, Pia Gattinger, Julia M. Berger, Wolfgang Trutschnig, Arne C. Bathke, et al. (+13)
8 [GO] 2022―Apr―11 Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer Annika Fendler, Scott T.C. Shepherd, Lewis Au, Katalin A. Wilkinson, Mary Wu, Andreas M. Schmitt, et al. (+58)
9 [GO] 2022―Apr―06 Augmentation of humoral and cellular immune responses after third-dose SARS-CoV-2 vaccination and viral neutralization in myeloma patients Adolfo Aleman, Oliver Van Oekelen, Bhaskar Upadhyaya, Katherine Beach, Ariel Kogan Zajdman, Hala Alshammary, et al. (+42)
10 [GO] 2022―Feb―24 Antibody responses following third mRNA COVID-19 vaccination in patients with cancer and potential timing of a fourth vaccination Sidse Ehmsen, Anders Asmussen, Stefan S. Jeppesen, Anna Christine Nilsson, Sabina Østerlev, Amalie Kragh, et al. (+2)
11 [GO] 2022―Feb―23 Efficacy of a third SARS-CoV-2 mRNA vaccine dose among hematopoietic cell transplantation, CAR T cell, and BiTE recipients Muhammad Bilal Abid, Micah Rubin, Nathan Ledeboer, Aniko Szabo, Walter Longo, Meera Mohan, et al. (+8)
12 [GO] 2022―Feb―22 Impact of COVID-19 on case fatality rate of patients with cancer during the Omicron wave Matthew Lee, Ryann Quinn, Kith Pradhan, Kateryna Fedorov, David Levitz, Ariel Fromowitz, et al. (+14)
13 [GO] 2022―Feb―16 Antibody response against SARS-CoV-2 Delta and Omicron variants after third-dose BNT162b2 vaccination in allo-HCT recipients Lorenzo Canti, Kevin K. Ariën, Isabelle Desombere, Stéphanie Humblet-Baron, Pieter Pannus, Leo Heyndrickx, et al. (+12)
14 [GO] 2022―Jan―25 Humoral and cellular responses to three doses of mRNA SARS-CoV-2 vaccines in a prospective cohort of CD19-targeted chimeric antigen receptor T cell immunotherapy recipients Pierre Sesques, Emmanuel Bachy, Emmanuelle Ferrant, Violaine Safar, Morgane Gossez, Florence Morfin-Sherpa, et al. (+2)
15 [GO] 2022―Jan―05 Neutralization breadth of SARS-CoV-2 viral variants following primary series and booster SARS-CoV-2 vaccines in patients with cancer Vivek Naranbhai, Kerri J. St. Denis, Evan C. Lam, Onosereme Ofoman, Wilfredo F. Garcia-Beltran, Cristhian B. Mairena, et al. (+40)
16 [GO] 2021―Dec―30 COVID-19 mRNA booster vaccines elicit strong protection against SARS-CoV-2 Omicron variant in patients with cancer Cong Zeng, John P. Evans, Karthik Chakravarthy, Panke Qu, Sarah Reisinger, No Joon Song, et al. (+4)
17 [GO] 2021―Dec―29 Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer Annika Fendler, Scott T.C. Shepherd, Lewis Au, Katalin A. Wilkinson, Mary Wu, Andreas M. Schmitt, et al. (+57)
18 [GO] 2021―Dec―13 Repeated vaccination against SARS-CoV-2 elicits robust polyfunctional T cell response in allogeneic stem cell transplantation recipients Patrick Harrington, Katie J. Doores, Chandan Saha, Jamie Saunders, Fiona Child, Richard Dillon, et al. (+13)
19 [GO] 2021―Dec―09 Attenuated response to SARS-CoV-2 vaccine in patients with asymptomatic precursor stages of multiple myeloma and Waldenstrom macroglobulinemia Yoshinobu Konishi, Romanos Sklavenitis-Pistofidis, Hong Yue, Federico Ferrari, Robert A. Redd, Elizabeth D. Lightbody, et al. (+15)
20 [GO] 2021―Nov―16 Efficacy of booster doses in augmenting waning immune responses to COVID-19 vaccine in patients with cancer Lauren C. Shapiro, Astha Thakkar, Sean T. Campbell, Stefanie K. Forest, Kith Pradhan, Jesus D. Gonzalez-Lugo, et al. (+18)
21 [GO] 2021―Oct―20 Variable cellular responses to SARS-CoV-2 in fully vaccinated patients with multiple myeloma Adolfo Aleman, Bhaskar Upadhyaya, Kevin Tuballes, Katerina Kappes, Charles.R. Gleason, Katherine Beach, et al. (+36)
22 [GO] 2021―Oct―13 Humoral and cellular immunity to delayed second dose of SARS-CoV-2 BNT162b2 mRNA vaccination in patients with cancer Duncan R. McKenzie, Miguel Muñoz-Ruiz, Leticia Monin, Thanussuyah Alaguthurai, Thomas Lechmere, Sultan Abdul-Jawad, et al. (+22)
23 [GO] 2021―Oct―13 Repeated vaccination against SARS-CoV-2 elicits robust polyfunctional T cell response in allogeneic stem cell transplantation recipients Patrick Harrington, Katie J. Doores, Chandan Saha, Jamie Saunders, Fiona Child, Richard Dillon, et al. (+13)
24 [GO] 2021―Sep―07 Anti-spike antibody response to SARS-CoV-2 booster vaccination in patients with B cell-derived hematologic malignancies Lee M. Greenberger, Larry A. Saltzman, Jonathon W. Senefeld, Patrick W. Johnson, Louis J. DeGennaro, Gwen L. Nichols
25 [GO] 2021―Aug―17 Humoral and cellular immune responses in SARS-CoV-2 mRNA-vaccinated patients with cancer Mario Mairhofer, Lea Kausche, Sabine Kaltenbrunner, Riad Ghanem, Maike Stegemann, Katharina Klein, et al. (+11)
26 [GO] 2021―Jul―29 COVID-19 provides an opportunity to transform cancer research Raffaella Casolino, Andrew V. Biankin
27 [GO] 2021―Jul―27 Antibody and T cell immune responses following mRNA COVID-19 vaccination in patients with cancer Sidse Ehmsen, Anders Asmussen, Stefan S. Jeppesen, Anna Christine Nilsson, Sabina Østerlev, Hanne Vestergaard, et al. (+4)
28 [GO] 2021―Jul―22 Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies Lee M. Greenberger, Larry A. Saltzman, Jonathon W. Senefeld, Patrick W. Johnson, Louis J. DeGennaro, Gwen L. Nichols
29 [GO] 2021―Jul―03 Immune responses to COVID-19 vaccines in patients with cancer: Promising results and a note of caution Elizabeth A. Griffiths, Brahm H. Segal
30 [GO] 2021―Jul―01 Recovery of cancer screening tests and possible associated disparities after the first peak of the COVID-19 pandemic Chris Labaki, Ziad Bakouny, Andrew Schmidt, Stuart R. Lipsitz, Timothy R. Rebbeck, Quoc-Dien Trinh, Toni K. Choueiri
31 [GO] 2021―Jun―29 Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma Oliver Van Oekelen, Charles R. Gleason, Sarita Agte, Komal Srivastava, Katherine Beach, Adolfo Aleman, et al. (+26)
32 [GO] 2021―Jun―26 Immunogenicity of a heterologous COVID-19 vaccine after failed vaccination in a lymphoma patient Joshua A. Hill, Chaitra S. Ujjani, Alexander L. Greninger, Mazyar Shadman, Ajay K. Gopal
33 [GO] 2021―Jun―18 Sustained cancer clinical trial activity in a French hospital during the first wave of the COVID-19 pandemic Arnaud Bayle, Capucine Baldini, Patricia Martin-Romano, Jean-Marie Michot, Stéphane Champiat, Rastilav Bahleda, et al. (+13)
34 [GO] 2021―Jun―18 Immunogenicity of SARS-CoV-2 messenger RNA Vaccines in Patients with Cancer Alfredo Addeo, Pankil K. Shah, Natacha Bordry, Robert D. Hudson, Brenna Albracht, Mariagrazia Di Marco, et al. (+14)
35 [GO] 2021―Jun―05 Seroconversion rates following COVID-19 vaccination amongst patients with cancer Astha Thakkar, Jesus D. Gonzalez-Lugo, Niyati Goradia, Radhika Gali, Lauren C. Shapiro, Kith Pradhan, et al. (+17)
36 [GO] 2021―May―07 Translating inspiration from COVID-19 vaccine trials to innovations in clinical cancer research Noura J. Choudhury, Gregory J. Riely, Paul J. Sabbatini, Matthew D. Hellmann
37 [GO] 2021―Apr―16 Care without a compass: including patients with cancer in COVID-19 studies Christopher R. Friese, Toni K. Choueiri, Narjust Duma, Dimitrios Farmakiotis, Petros Grivas, Brian I. Rini, et al. (+5)
38 [GO] 2021―Jan―18 Inflammatory leptomeningeal cytokines mediate COVID-19 neurologic symptoms in cancer patients Jan Remsik, Jessica A. Wilcox, N. Esther Babady, Tracy A. McMillen, Behroze, A. Vachha, et al. (+7)
39 [GO] 2021―Jan―09 Changes in Treatment Behavior during the COVID-19 Pandemic among Patients at a Cancer Hospital Yasuyoshi Sato, Yu Fujiwara, Naoki Fukuda, Brian Hayama, Yoshinori Ito, Shinji Ohno, Shunji Takahashi
40 [GO] 2021―Jan―09 Acute immune signatures and their legacies in severe acute respiratory syndrome coronavirus-2 infected cancer patients Sultan Abdul-Jawad, Luca Baé, Thanussuyah Alaguthurai, Irene del Molino del Barrio, Adam G. Laing, Thomas S. Hayday, et al. (+45)
41 [GO] 2020―Dec―10 Utility of Preoperative Computed Tomography Scans for Coronavirus Disease in a Cancer Treatment Center Yukinori Ozaki, Jun Masuda, Akemi Kataoka, Katsunori Oikado, Natsue Uehiro, Lina Inagaki, et al. (+5)
42 [GO] 2020―Nov―03 Cancer Care Disparities during the COVID-19 Pandemic: COVID-19 and Cancer Outcomes Study Andrew L. Schmidt, Ziad Bakouny, Sheena Bhalla, John A. Steinharter, Douglas A. Tremblay, Mark M. Awad, et al. (+23)
43 [GO] 2020―Oct―30 A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19:CCC19 Governance, Protocol, and Quality Assurance
44 [GO] 2020―Oct―13 The HOLA COVID-19 Study: An International Effort to Determine How COVID-19 Has Impacted Oncology Practices in Latin America Carolina Bernabé, Ana I. Velázquez, Coral Olazagasti, Cristiane Decat Bergerot, Paulo Gustavo Bergerot, Enrique Soto Pérez de Celis, Narjust Duma
45 [GO] 2020―Oct―10 COVID-19: Staging of a New Disease Carlos Cordon-Cardo, Elisabet Pujadas, Ania Wajnberg, Robert Sebra, Gopi Patel, Adolfo Firpo-Betancourt, et al. (+11)
46 [GO] 2020―Oct―09 A Lung Cancer Patient with Dyspnea: Diagnostic Difficulties during the COVID-19 Pandemic Melinda A. Pruis, Burhan Hussain, Marleen Bakker, Rogier A.S. Hoek, Jelle R. Miedema, Anne-Marie C. Dingemans, Marthe S. Paats
47 [GO] 2020―Oct―08 Impact of COVID-19 Pandemic on Cancer Research Steve Mao
48 [GO] 2020―Oct―05 Supporting Clinical Decision-Making, during the SARS-CoV-2 Pandemic through a Global Research Commitment: The TERAVOLT Experience Annalisa Trama, Claudia Proto, Jennifer G. Whisenant, Valter Torri, Alessio Cortellini, Olivier Michielin, et al. (+14)
49 [GO] 2020―Oct―02 Cytokine Storms in Cancer and COVID-19 Casmir Turnquist, Bríd M. Ryan, Izumi Horikawa, Brent T. Harris, Curtis C. Harris
50 [GO] 2020―Oct―02 Screening for COVID-19 in Symptomatic Cancer Patients in a Cancer Hospital Yu Fujiwara, Yasuyoshi Sato, Xiaofei Wang, Katsunori Oikado, Yoshinao Sato, Naoki Fukuda, et al. (+17)
51 [GO] 2020―Oct―01 COVID-19 and Cancer:Current Challenges and Perspectives Ziad Bakouny, Jessica E. Hawley, Toni K. Choueiri, Solange Peters, Brian I. Rini, Jeremy L. Warner, Corrie A. Painter
52 [GO] 2020―Sep―15 SARS-CoV-2 Viral Load Predicts Mortality in Patients with and without Cancer Who Are Hospitalized with COVID-19 Lars F. Westblade, Gagandeep Brar, Laura C. Pinheiro, Demetrios Paidoussis, Mangala Rajan, Peter Martin, et al. (+15)
53 [GO] 2020―Jul―25 Cancer Patients and Risk of Mortality for COVID-19 Giuseppe Curigliano
54 [GO] 2020―Jul―24 Utility of COVID-19 Screening in Cancer Patients Lennard Y.W. Lee, Thomas Hill, Oliver Topping, Michael Tilby, Mark Baker, Julian Greig, et al. (+24)
55 [GO] 2020―Jul―06 Digitalized Adaptation of Oncology Trials during and after COVID-19 Guanqiao Li, Chen Yin, Yangzhong Zhou, Tongyan Wang, Jing Chen, Yang Liu, et al. (+4)
56 [GO] 2020―May―16 TERAVOLT: Thoracic Cancers International COVID-19 Collaboration Jennifer G. Whisenant, Annalisa Trama, Valter Torri, Alessandro De Toma, Giuseppe Viscardi, Alessio Cortellini, et al. (+11)
57 [GO] 2020―May―16 NCI’s Work to Advance Cancer Research while Responding to the COVID-19 Pandemic Dinah S. Singer
58 [GO] 2020―May―14 Cancer Patient Care during COVID-19 Amer Harky, Chun Ming Chiu, Thomas Ho Lai Yau, Sheung Heng Daniel Lai
59 [GO] 2020―May―11 Cancer Research after COVID-19: Where Do We Go from Here? Lauren E. Colbert, Ramez Kouzy, Joseph Abi Jaoude, Ethan B. Ludmir, Cullen M. Taniguchi
60 [GO] 2020―Apr―29 The COVID-19 & Cancer Consortium (CCC19): a collaborative effort to understand the effects of COVID-19 on patients with cancer Samuel Rubinstein, John A. Steinharter, Jeremy Warner, Brian I. Rini, Solange Peters, Toni K. Choueiri
 [1] 

60 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.005 sec